Revance Therapeutics (RVNC:NASDAQ)

The global Botulinum Toxin (Botox) market is expected to hit $9.09 billion by 2029, and RVNC is looking to secure a piece of the pie with their innovative new DAXXIFY product. DAXXIFY was recently accepted for review by the FDA in order to help treat cervical dystonia in adults, having already been evaluated in two Phase 3 clinical studies. 

As an investor, I am bullish on RVNC as long as the stock remains above $30-$31 and has an upside target of $42-$44. It’s exciting times for both RVNC and investors looking for a good opportunity!

S&P 500 (SPX)

Two weeks ago, the SPX made a huge move by decisively breaking through its weekly descending resistance line at 4,000. This was obviously a bullish action and price moved higher to test the following resistance of 4,300. 

In this instance the resistance held, but it is worth noting that if or when the SPX retraces back down to that now supportive level at 4,000 there could be further upside pressure as traders look to buy on the dip. This support will ultimately decide if we can see further gains in prices while also providing an indication of future market sentiment.

LDO/USDT

Although it’s been a volatile year in the markets, there is some hope for LDO – a token that has created quite a bit of buzz. After overcoming a significant level of resistance and holding so far, it appears likely that the upward trend has only just begun. With further hikes in price predicted, it could mean big things ahead for the project which is attracting more and more attention with each passing day. 

For now, everything is seemingly looking bright for LDO, as long as traders can keep momentum up at these levels.

MATIC/USDT

The price reached $1.35, which is currently acting as a critical resistance. The support is at $1, and so long MATIC holds above this level, the bias will remain bullish.

However, buyers need to be cautious because this last push has created a bearish divergence on the RSI and MACD indicators. If the volume declines, then a retest of the key support will become more likely. 

The last time MATIC broke above $1, buyers failed to hold the price above this key psychological level. Failure to do so would likely result in a further decrease.